#Bardy diagnostics inc Patch#
In addition, the CAM patch design has drastically improved patient compliance in this pediatric group. “The CAM patch offers three market-leading competitive advantages of advanced diagnostic accuracy, patient-friendly design, and physician-friendly flexibility,” says Nelson.Īs an example, deploying Bardy Diagnostics’ services has enabled a renowned pediatric academic hospital to identify in their patient population previously undiagnosable arrhythmias using traditional monitors, like atrioventricular reentrant tachycardia (AVRT) and AV node reentrant tachycardia (AVNRT). In addition, the product is available in 48-hour and 7-day recording options to provide physician-friendly flexibility. It is the only device designed to be comfortable for women. The CAM patch can be comfortably and discreetly worn by men, women, and children, while improving patient compliance with its lifestyle-enabling patch design that permits exercising, sleeping, and showering while the device is worn. The CAM patch offers three market-leading competitive advantages of advanced diagnostic accuracy, patient-friendly design, and physician-friendly flexibility The unique narrow hourglass shape of the patch is well-suited for placement upon the sternum directly over the atria for optimum recording. Furthermore, CAM patch’s diagnostic accuracy is substantiated by head-to-head clinical trials against Holter monitors and other competitive products. Chief Commercial Officer at Bardy Diagnostics, Ken Nelson explains, “It is like competitive products look at a P-wave through binoculars, and we can view the P-wave through a microscope.” In addition, the CAM patch provides visualization of the R-waves (correlating ventricular rhythm) as well, enabling accurate and definitive arrhythmia diagnosis. The CAM patch’s P-wave focused technology has an extremely low noise floor of 2.5 microvolts, which enables recognizing the often difficult-to-detect P-wave, thus delivering optimal ECG clarity unlike traditional Holter monitors. It is the P-wave that is central to understanding an arrhythmia’s origin. The company’s Carnation Ambulatory Monitor (CAM™) patch is a non-invasive P-wave centric arrhythmia detection device. He founded Bardy Diagnostics to assist physicians in the accurate diagnoses and treatment of arrhythmia-related cardiac diseases and prevention of sudden cardiac death.
The source of his dedication was due to the loss of his wife to a rare heart rhythm disorder that was not identified using traditional cardiac monitors. patents, took up the task of completely redesigning arrhythmia monitors with optimal signal detection, comfort, and ease of use.
Gust Bardy, an established electrophysiologist with decades of experience in designing cardiac devices and possessing over 200 U.S. Traditional cardiac monitors are large, bulky, and uncomfortable and typically record noisy signals, proving ineffective at accurately providing user-friendly arrhythmia diagnosis and monitoring.
Ken Nelson, Chief Commercial Officer Life-threatening cardiac arrhythmias are recognized as critical cardiac disorders that can impair the heart’s ability to pump enough blood, resulting in death. Medical Device Testing and Certification.Medical Device Regulatory and Compliance.
0 kommentar(er)
